Vistagen amends executive severance plan
- Amended plan effective Oct 7, 2026
- Expands severance benefits for involuntary terminations
- Includes COBRA premium payments
Every EDGAR filing for Vistagen Therapeutics, Inc. (VTGN), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
Ownership stake disclosure by TCG Crossover GP I, LLC (amended)
TCG Crossover GP I, LLC, filed by
Douglas J Williamson, insider filing for VTGN
Douglas J Williamson, reporting
Reid G. Adler, insider filing for VTGN
Reid G. Adler, reporting
Angel S Angelov, new insider at VTGN
Angel S Angelov, reporting
Ownership stake disclosure by TCG Crossover GP II, LLC (amended)
TCG Crossover GP II, LLC, filed by
Nick B. Tressler, insider filing for VTGN
Nick B. Tressler, reporting
Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
Ownership stake disclosure by Commodore Capital LP (amended)
Commodore Capital LP, filed by
Ownership stake disclosure by JANUS HENDERSON GROUP PLC (amended)
JANUS HENDERSON GROUP PLC, filed by
Ownership stake disclosure by STEMPOINT CAPITAL LP (amended)
STEMPOINT CAPITAL LP, filed by
Ownership stake disclosure by Nantahala Capital Management, LLC (amended)
Nantahala Capital Management, LLC, filed by